All In MedTech

Device Trial Radar · NCT02835391

PerClot Compared to Usual Care in Gynaecology Procedures

A Prospective, Multi-Centre, Randomized, Safety and Effectiveness Study of PerClot Compared to Usual Care When Used During Gynaecology Procedures

Last checked: Nov 19, 2026Latest source record: Sep 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

90

Actual

Start

Nov 2015

Primary completion

Jul 2017

Study completion Aug 2017

Sponsor

Lead sponsor
CryoLife EuropaPublic (AORT)
Sponsor type
Industry
First posted
Jul 18, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a post market, multi-centre, randomised study evaluating PerClot compared to usual care. PerClot is a CE marked device and is currently used as a haemostat in gynaecological surgery throughout Europe. The purpose of this study is to collect additional post market data on its use in this indication.

Conditions

  • Endometriosis
  • Ovarian Cyst
  • Menorrhagia
  • Cancer
  • Uterine Fibroids

Interventions

  • PerClotDevice

    Haemostatic device for the control of bleeding from capillary, venous or arteriolar vessels by pressure, ligature or other conventional means is either ineffective or impractical.

  • Floseal, Surgicel, Surgiflo, AristaDevice

    Haemostatic device for the control of bleeding

  • Electrocautery/DiatermyProcedure

    Procedure for the control of bleeding

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. achievement of haemostasis (yes/no).Time frame: measured up to 10 minutes after application

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bellvitge Hospital

    Barcelona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.